Jianmin Wang, PhD, MD

Director, Biostatistics, US

PhD, Biostatistics
MPH, Biostatistics
University of North Carolina, Chapel Hill, NC

MS, Biostatistics
Chinese Academy of Preventive Medicine, Beijing, China

Xinjiang Medical College, Xinjiang, China

Jianmin Wang, PhD, MD, is a Director of Biostatistics, US, in RTI-HS. He began his career in statistics in 1983, and has used SAS software since 1987. He accumulated extensive collaborative research experience with medical and public health professionals. Before joining RTI-HS, Dr. Wang was the Senior Biostatistician at the Gynecological Oncology Group (GOG), where he developed the statistical sections for numerous research protocols and analyzed data from clinical trials and experimental medicine studies. He was a research assistant professor in the Department of Biostatistics at the University of Buffalo from 2004 to 2005. In GOG, Dr. Wang developed an extensive background in clinical trials while participating in the development of protocols and statistical analysis plans for clinical trials. Dr. Wang’s widely published work covers topics such as the risk of development of advanced prostate cancer, radiation and chemotherapy after radical hysterectomy, disease progression in patients with epithelial ovarian cancer, and patient survival in lung cancer.